REG - Tristel PLC - Director Option Grant

TristelAnnouncement

Today 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251124:nRSX7639Ia&default-theme=true

RNS Number : 7639I  Tristel PLC  24 November 2025

TRISTEL plc

("Tristel" or the "Company")

 

Director Option Grant

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that on 24 November 2025 it granted a total of 181,972 new share
options (the "Options") over ordinary shares of 1 pence each ("Ordinary
Shares") under the Long Term Incentive Plan ("LTIP") in the Company, to two
directors as follows:

 

 Director's name  Position  Number of Options granted  Aggregate number of options post grant  Current total beneficial holding of Ordinary Shares  Current holding as a % of Issued share capital
 Matt Sassone     CEO       106,479                    183,483                                 3,500                                                0.01%
 Anna Wasyl       CFO       75,493                     75,493                                  0                                                    0%

 

Terms of the new LTIP

The performance targets for the LTIP awards, which have been adjusted to
reflect the impact of the tax rate and the investments required to stimulate
growth, will be 50% based on earning per share (EPS) targets and 50% based on
relative total shareholder return (TSR) versus the constituents of the AIM 100
as at the grant of the awards as follows:

 

 50% of Initial awards                          50% of Initial awards
 EPS FY 27/28         % of EPS Part that Vests  Relative TSR measured over 3 years from grant  % of TSR Part that Vests
 Less than 19p        0%                        Below median                                   0%
 Between 19p and 23p  Pro-rata 25% to 100%      Between median and upper quartile              Pro-rata 25% to 100%
 23p or better        100%                      Upper quartile or above                        100%

 

This announcement was deemed by the company to contain inside information as
stipulated under the Market Abuse Regulations (EU) no. 596/2014 as they form
part of UK domestic law by virtue of the European Union (withdrawal) Act 2018.
With the publication of this announcement, this information is now considered
to be in the public domain.

 

 

For further information please contact:

 Tristel plc                                                                Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                      www.investors.tristel.com (http://www.investors.tristel.com/)
 Anna Wasyl, Chief Financial Officer

 Walbrook PR Ltd                                                            Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Anna Dunphy    Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

 Cavendish Capital Markets Ltd                                              Tel: 020 7220 0500
 Geoff Nash / Callum Davidson / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 20
subsidiaries selling into 40+ countries. The Company targets double digit
revenue growth annually and an EBITDA margin of at least 25% and the business
is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

 

The information set out below is provided in accordance with the requirements
of Article 19(3) of the EU Market Abuse Regulation No 596/2014 which forms
part of UK Law by virtue of the European Union (Withdrawal) Act 2018.

 

 

 1.    Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         Matthew Sassone
 2.    Reason for the Notification
 a)    Position/status                                              CEO
 b)    Initial notification/Amendment                               Initial notification
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Tristel plc
 b)    LEI                                                          2138009DZ4LH9CZGF662
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the Financial instrument, type of instrument  Ordinary shares of 1p each
       Identification code                                          GB00B07RVT99
 b)    Nature of the transaction                                    Grant of options
 c)    Price(s) and volume(s)                                       1 pence, 106,479 shares

 d)    Aggregated information:                                      See above

       · Aggregated volume

       · Price
 e)    Date of the transaction                                      24 November 2025
 f)    Place of the transaction                                     Outside of a trading venue

 

 

 1.    Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         Anna Wasyl
 2.    Reason for the Notification
 a)    Position/status                                              CFO
 b)    Initial notification/Amendment                               Initial notification
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Tristel plc
 b)    LEI                                                          2138009DZ4LH9CZGF662
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the Financial instrument, type of instrument  Ordinary shares of 1p each
       Identification code                                          GB00B07RVT99
 b)    Nature of the transaction                                    Grant of options
 c)    Price(s) and volume(s)                                       1 pence, 75,493 shares

 d)    Aggregated information:                                      See above

       · Aggregated volume

       · Price
 e)    Date of the transaction                                      24 November 2025
 f)    Place of the transaction                                     Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPKQBBBBDDBDB



            Copyright 2019 Regulatory News Service, all rights reserved